0001786286 false Q1 2023-03-31 2023 --12-31 SK 0001786286 2023-01-01 2023-03-31 0001786286 2023-03-31 0001786286 2022-12-31 0001786286 2022-01-01 2022-03-31 0001786286 ifrs-full:IssuedCapitalMember 2021-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2021-12-31 0001786286 ifrs-full:RetainedEarningsMember 2021-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2021-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2021-12-31 0001786286 2021-12-31 0001786286 ifrs-full:IssuedCapitalMember 2022-03-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2022-03-31 0001786286 ifrs-full:RetainedEarningsMember 2022-03-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2022-03-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2022-03-31 0001786286 2022-03-31 0001786286 ifrs-full:IssuedCapitalMember 2022-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2022-12-31 0001786286 ifrs-full:RetainedEarningsMember 2022-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2022-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2022-12-31 0001786286 ifrs-full:IssuedCapitalMember 2022-01-01 2022-03-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2022-01-01 2022-03-31 0001786286 ifrs-full:RetainedEarningsMember 2022-01-01 2022-03-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2022-01-01 2022-03-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2022-01-01 2022-03-31 0001786286 ifrs-full:IssuedCapitalMember 2022-04-01 2022-12-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2022-04-01 2022-12-31 0001786286 ifrs-full:RetainedEarningsMember 2022-04-01 2022-12-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2022-04-01 2022-12-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2022-04-01 2022-12-31 0001786286 2022-04-01 2022-12-31 0001786286 ifrs-full:IssuedCapitalMember 2023-01-01 2023-03-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-01-01 2023-03-31 0001786286 ifrs-full:RetainedEarningsMember 2023-01-01 2023-03-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2023-01-01 2023-03-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-01-01 2023-03-31 0001786286 ifrs-full:IssuedCapitalMember 2023-03-31 0001786286 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-03-31 0001786286 ifrs-full:RetainedEarningsMember 2023-03-31 0001786286 ifrs-full:ReserveOfGainsAndLossesFromInvestmentsInEquityInstrumentsMember 2023-03-31 0001786286 ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember 2023-03-31 0001786286 DPRO:DragonflyInnovationsIncMember 2023-01-01 2023-03-31 0001786286 DPRO:DragonflyInnovationsUSAIncMember 2023-01-01 2023-03-31 0001786286 DPRO:DronelogicsSystemsIncMember 2023-01-01 2023-03-31 0001786286 DPRO:InventoryMember 2023-01-01 2023-03-31 0001786286 DPRO:InventoryMember 2022-01-01 2022-03-31 0001786286 DPRO:NoteOneMember 2023-01-01 2023-03-31 0001786286 2022-10-20 2022-10-21 0001786286 DPRO:NoteOneMember 2023-01-29 2023-01-30 0001786286 DPRO:NoteOneMember DPRO:NonadjustingEventsRelatedPartyPaymentMember 2023-04-27 2023-04-30 0001786286 DPRO:NoteOneMember DPRO:NonadjustingEventsRelatedPartyPaymentMember 2023-04-27 2023-04-28 0001786286 DPRO:PublicCompanySharesMember 2023-03-31 0001786286 DPRO:PrivateCompanySharesMember 2023-03-31 0001786286 2021-03-09 2021-03-10 0001786286 2021-03-10 0001786286 2021-10-25 2021-10-27 0001786286 DPRO:WarrantsMember 2022-01-01 2022-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2021-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2021-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2021-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2021-12-31 0001786286 ifrs-full:VehiclesMember 2021-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2022-01-01 2022-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2022-01-01 2022-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2022-01-01 2022-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2022-01-01 2022-12-31 0001786286 ifrs-full:VehiclesMember 2022-01-01 2022-12-31 0001786286 2022-01-01 2022-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2022-12-31 0001786286 DPRO:FurnitureAndEquipmentMember 2022-12-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2022-12-31 0001786286 ifrs-full:ComputerSoftwareMember 2022-12-31 0001786286 ifrs-full:VehiclesMember 2022-12-31 0001786286 ifrs-full:ComputerEquipmentMember 2023-01-01 2023-03-31 0001786286 DPRO:FurnitureAndEquipmentMember 2023-01-01 2023-03-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2023-01-01 2023-03-31 0001786286 ifrs-full:ComputerSoftwareMember 2023-01-01 2023-03-31 0001786286 ifrs-full:VehiclesMember 2023-01-01 2023-03-31 0001786286 ifrs-full:ComputerEquipmentMember 2023-03-31 0001786286 DPRO:FurnitureAndEquipmentMember 2023-03-31 0001786286 ifrs-full:LeaseholdImprovementsMember 2023-03-31 0001786286 ifrs-full:ComputerSoftwareMember 2023-03-31 0001786286 ifrs-full:VehiclesMember 2023-03-31 0001786286 ifrs-full:GrossCarryingAmountMember DPRO:PatentMember 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:GoodwillMember 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember 2022-12-31 0001786286 ifrs-full:GrossCarryingAmountMember DPRO:PatentMember 2023-01-01 2023-03-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-01-01 2023-03-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2023-01-01 2023-03-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2023-01-01 2023-03-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:GoodwillMember 2023-01-01 2023-03-31 0001786286 ifrs-full:GrossCarryingAmountMember 2023-01-01 2023-03-31 0001786286 ifrs-full:GrossCarryingAmountMember DPRO:PatentMember 2023-03-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-03-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2023-03-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2023-03-31 0001786286 ifrs-full:GrossCarryingAmountMember ifrs-full:GoodwillMember 2023-03-31 0001786286 ifrs-full:GrossCarryingAmountMember 2023-03-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember DPRO:PatentMember 2021-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2021-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:BrandNamesMember 2021-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2021-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:GoodwillMember 2021-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2021-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember DPRO:PatentMember 2022-01-01 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-01-01 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:BrandNamesMember 2022-01-01 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2022-01-01 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:GoodwillMember 2022-01-01 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2022-01-01 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember DPRO:PatentMember 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:BrandNamesMember 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:GoodwillMember 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2022-12-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember DPRO:PatentMember 2023-01-01 2023-03-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-01-01 2023-03-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:BrandNamesMember 2023-01-01 2023-03-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2023-01-01 2023-03-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:GoodwillMember 2023-01-01 2023-03-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2023-01-01 2023-03-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember DPRO:PatentMember 2023-03-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-03-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:BrandNamesMember 2023-03-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:ComputerSoftwareMember 2023-03-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember ifrs-full:GoodwillMember 2023-03-31 0001786286 ifrs-full:AccumulatedDepreciationAndAmortisationMember 2023-03-31 0001786286 DPRO:PatentMember 2022-12-31 0001786286 ifrs-full:CustomerrelatedIntangibleAssetsMember 2022-12-31 0001786286 ifrs-full:BrandNamesMember 2022-12-31 0001786286 ifrs-full:GoodwillMember 2022-12-31 0001786286 DPRO:PatentMember 2023-03-31 0001786286 ifrs-full:CustomerrelatedIntangibleAssetsMember 2023-03-31 0001786286 ifrs-full:BrandNamesMember 2023-03-31 0001786286 ifrs-full:GoodwillMember 2023-03-31 0001786286 ifrs-full:NotLaterThanOneYearMember 2023-03-31 0001786286 ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember 2023-03-31 0001786286 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember 2023-03-31 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2023-03-31 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2022-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountMember 2023-01-01 2023-03-31 0001786286 DPRO:CanadaEmergencyBusinessAccountLoanMember 2023-03-31 0001786286 DPRO:CanadaEmergencyBusinessAccountLoanMember 2022-12-31 0001786286 DPRO:CanadaEmergencyBusinessAccountLoanMember 2023-01-01 2023-03-31 0001786286 DPRO:VehicleLoanMember 2023-03-31 0001786286 DPRO:VehicleLoanMember 2022-12-31 0001786286 DPRO:VehicleLoanMember 2023-01-01 2023-03-31 0001786286 DPRO:RestrictedStockUnitsMember 2023-01-01 2023-03-31 0001786286 DPRO:CommonSharesMember 2023-01-01 2023-03-31 0001786286 DPRO:CommonStock1Member 2022-01-01 2022-12-31 0001786286 DPRO:StockOptionsMember 2023-01-01 2023-03-31 0001786286 DPRO:StockOptionsMember 2022-01-01 2022-03-31 0001786286 DPRO:RestrictedStockUnitsMember 2022-01-01 2022-03-31 0001786286 2021-03-21 2021-03-22 0001786286 DPRO:ExercisePriceOneMember DPRO:IncentiveShareCompensationPlanMember 2023-01-01 2023-03-31 0001786286 DPRO:ExercisePriceOneMember DPRO:IncentiveShareCompensationPlanMember 2023-03-31 0001786286 DPRO:ExercisePriceTwoMember DPRO:IncentiveShareCompensationPlanMember 2023-01-01 2023-03-31 0001786286 DPRO:ExercisePriceTwoMember DPRO:IncentiveShareCompensationPlanMember 2023-03-31 0001786286 DPRO:ExercisePriceThreeMember DPRO:IncentiveShareCompensationPlanMember 2023-01-01 2023-03-31 0001786286 DPRO:ExercisePriceThreeMember DPRO:IncentiveShareCompensationPlanMember 2023-03-31 0001786286 DPRO:ExercisePriceFourMember DPRO:IncentiveShareCompensationPlanMember 2023-01-01 2023-03-31 0001786286 DPRO:ExercisePriceFourMember DPRO:IncentiveShareCompensationPlanMember 2023-03-31 0001786286 DPRO:ExercisePriceFiveMember DPRO:IncentiveShareCompensationPlanMember 2023-01-01 2023-03-31 0001786286 DPRO:ExercisePriceFiveMember DPRO:IncentiveShareCompensationPlanMember 2023-03-31 0001786286 DPRO:ExercisePriceSixMember DPRO:IncentiveShareCompensationPlanMember 2023-01-01 2023-03-31 0001786286 DPRO:ExercisePriceSixMember DPRO:IncentiveShareCompensationPlanMember 2023-03-31 0001786286 DPRO:ExercisePriceSevenMember DPRO:IncentiveShareCompensationPlanMember 2023-01-01 2023-03-31 0001786286 DPRO:ExercisePriceSevenMember DPRO:IncentiveShareCompensationPlanMember 2023-03-31 0001786286 DPRO:ExercisePriceEightMember DPRO:IncentiveShareCompensationPlanMember 2023-01-01 2023-03-31 0001786286 DPRO:ExercisePriceEightMember DPRO:IncentiveShareCompensationPlanMember 2023-03-31 0001786286 DPRO:ExercisePriceNineMember DPRO:IncentiveShareCompensationPlanMember 2023-01-01 2023-03-31 0001786286 DPRO:ExercisePriceNineMember DPRO:IncentiveShareCompensationPlanMember 2023-03-31 0001786286 DPRO:ExercisePriceTenMember DPRO:IncentiveShareCompensationPlanMember 2023-01-01 2023-03-31 0001786286 DPRO:ExercisePriceTenMember DPRO:IncentiveShareCompensationPlanMember 2023-03-31 0001786286 DPRO:IncentiveShareCompensationPlanMember 2023-03-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2021-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2022-01-01 2022-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2022-12-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2023-01-01 2023-03-31 0001786286 DPRO:IfrsRestrictedStockUnitsRsuMember 2023-03-31 0001786286 DPRO:WarrantsMember 2021-12-31 0001786286 DPRO:WarrantsMember 2022-01-01 2022-12-31 0001786286 DPRO:WarrantsMember 2022-12-31 0001786286 DPRO:WarrantsMember 2023-03-31 0001786286 DPRO:WarrantsMember 2023-01-01 2023-03-31 0001786286 DPRO:Range1Member 2023-01-01 2023-03-31 0001786286 DPRO:Range1Member 2023-03-31 0001786286 DPRO:Range1Member 2022-12-31 0001786286 DPRO:Range2Member 2023-01-01 2023-03-31 0001786286 DPRO:Range2Member 2023-03-31 0001786286 DPRO:Range2Member 2022-12-31 0001786286 DPRO:Range3Member 2023-01-01 2023-03-31 0001786286 DPRO:Range3Member 2023-03-31 0001786286 DPRO:Range3Member 2022-12-31 0001786286 DPRO:Range4Member 2023-01-01 2023-03-31 0001786286 DPRO:Range4Member 2023-03-31 0001786286 DPRO:Range4Member 2022-12-31 0001786286 DPRO:WarrantsMember ifrs-full:BottomOfRangeMember 2022-01-01 2022-12-31 0001786286 DPRO:WarrantsMember ifrs-full:TopOfRangeMember 2022-01-01 2022-12-31 0001786286 DPRO:WarrantsMember 2021-12-31 0001786286 DPRO:WarrantsMember 2022-12-31 0001786286 DPRO:WarrantsMember 2023-01-01 2023-03-31 0001786286 DPRO:WarrantsMember 2023-03-31 0001786286 DPRO:WarrantOneMember 2023-01-01 2023-03-31 0001786286 DPRO:WarrantOneMember 2023-03-31 0001786286 DPRO:WarrantTwoMember 2023-01-01 2023-03-31 0001786286 DPRO:WarrantTwoMember 2023-03-31 0001786286 DPRO:DronesMember 2023-01-01 2023-03-31 0001786286 DPRO:VitalMember 2023-01-01 2023-03-31 0001786286 DPRO:CorporatesMember 2023-01-01 2023-03-31 0001786286 DPRO:DronesMember 2022-01-01 2022-03-31 0001786286 DPRO:VitalMember 2022-01-01 2022-03-31 0001786286 DPRO:CorporatesMember 2022-01-01 2022-03-31 0001786286 country:CA 2023-01-01 2023-03-31 0001786286 country:CA 2022-01-01 2022-03-31 0001786286 country:US 2023-01-01 2023-03-31 0001786286 country:US 2022-01-01 2022-03-31 0001786286 DPRO:CEOAndDirectorMember 2023-01-01 2023-03-31 0001786286 DPRO:CEOAndDirectorMember 2022-01-01 2022-03-31 0001786286 DPRO:CEOMember 2023-01-01 2023-03-31 0001786286 DPRO:CEOMember 2022-01-01 2022-03-31 0001786286 DPRO:PresidentAndDirectorMember 2023-01-01 2023-03-31 0001786286 DPRO:PresidentAndDirectorMember 2022-01-01 2022-03-31 0001786286 ifrs-full:OtherRelatedPartiesMember 2023-01-01 2023-03-31 0001786286 ifrs-full:OtherRelatedPartiesMember 2022-01-01 2022-03-31 0001786286 DPRO:NonadjustingEventMember 2023-05-15 0001786286 ifrs-full:Level1OfFairValueHierarchyMember 2023-03-31 0001786286 ifrs-full:Level2OfFairValueHierarchyMember 2023-03-31 0001786286 ifrs-full:Level3OfFairValueHierarchyMember 2023-03-31 0001786286 ifrs-full:Level1OfFairValueHierarchyMember 2022-12-31 0001786286 ifrs-full:Level2OfFairValueHierarchyMember 2022-12-31 0001786286 ifrs-full:Level3OfFairValueHierarchyMember 2022-12-31 0001786286 DPRO:NonadjustingEventMember 2023-04-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares iso4217:CAD iso4217:CAD xbrli:shares xbrli:pure
Exhibit 99.1
Draganfly Inc.
Condensed Consolidated Interim Financial Statements - Unaudited
For the Three Months Ended March 31, 2023
(Expressed in Canadian Dollars)
Draganfly Inc.
Condensed Consolidated Interim Statements of Financial Position - Unaudited
Expressed in Canadian Dollars
| | | | | | | | | | | | | |
| | | | | | March 31, | | | December 31, | |
| As at | | Notes | | | 2023 | | | 2022 | |
| | | | | | | | | | |
| ASSETS | | | | | | | | | | | | |
| Current Assets | | | | | | | | | | | | |
| Cash and cash equivalents | | | 4 | | | $ | 13,368,936 | | | $ | 7,894,781 | |
| Receivables | | | 5 | | | | 1,485,994 | | | | 2,088,965 | |
| Inventory | | | 6 | | | | 1,537,247 | | | | 1,055,942 | |
| Note receivable | | | 7 | | | | 135,330 | | | | 169,300 | |
| Prepaids and Deposits | | | 8 | | | | 1,888,374 | | | | 2,307,724 | |
| Total current assets | | | | | | | 18,415,881 | | | | 13,516,712 | |
| | | | | | | | | | | | | |
| Equipment | | | 10 | | | | 427,869 | | | | 404,691 | |
| Intangible assets | | | 11 | | | | 170,812 | | | | 179,801 | |
| Investments | | | 9 | | | | 249,616 | | | | 192,583 | |
| Right of use assets | | | 12 | | | | 313,906 | | | | 344,746 | |
| TOTAL ASSETS | | | | | | $ | 19,578,084 | | | $ | 14,638,533 | |
| | | | | | | | | | | | | |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | | | | | | | | | | | | |
| Current Liabilities | | | | | | | | | | | | |
| Trade payables and accrued liabilities | | | 14 | | | $ | 3,208,718 | | | $ | 2,816,676 | |
| Customer deposits | | | | | | | 235,225 | | | | 194,758 | |
| Deferred income | | | 15 | | | | 3,958 | | | | 63,690 | |
| Loans payable | | | 16 | | | | 82,787 | | | | 81,512 | |
| Derivative liability | | | 17 | | | | - | | | | 57,314 | |
| Lease liabilities | | | 13 | | | | 108,898 | | | | 133,962 | |
| Total current liability | | | | | | | 3,639,586 | | | | 3,347,912 | |
| | | | | | | | | | | | | |
| Non-current Liabilities | | | | | | | | | | | | |
| Loans payable | | | 16 | | | | 3,373 | | | | 5,059 | |
| Lease liabilities | | | 13 | | | | 239,301 | | | | 244,681 | |
| TOTAL LIABILITIES | | | | | | | 3,882,260 | | | | 3,597,652 | |
| | | | | | | | | | | | | |
| SHAREHOLDERS’ EQUITY | | | | | | | | | | | | |
| Share capital | | | 17 | | | | 94,880,214 | | | | 83,600,089 | |
| Reserve – share-based payments | | | 17 | | | | 7,736,153 | | | | 7,264,340 | |
| Accumulated deficit | | | | | | | (87,044,172 | ) | | | (79,976,546 | ) |
| Accumulated other comprehensive income (loss) | | | | | | | 123,629 | | | | 152,998 | |
| TOTAL SHAREHOLDERS’ EQUITY | | | | | | | 15,695,824 | | | | 11,040,881 | |
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | | | | | | $ | 19,578,084 | | | $ | 14,638,533 | |
Nature and Continuance of Operations (Note 1)
Subsequent Event (Notes 7, 21, 22)
| “Scott Larson” | | “Cameron Chell” |
Approved and authorized for issuance by the Board of Directors on May 9, 2023.
The accompanying notes are an integral part of these consolidated interim financial statements.
Draganfly Inc.
Condensed Consolidated Interim Statements of Comprehensive Loss - Unaudited
Expressed in Canadian Dollars
| | | | | | | | | | | | | |
| | | | | | For the three months ended
March 31, | |
| | | Note | | | 2023 | | | 2022 | |
| REVENUE | | | | | | | | | | | | |
| Sales of goods | | | 18 | | | $ | 1,380,816 | | | $ | 1,637,716 | |
| Provision of services | | | 18 | | | | 220,670 | | | | 406,846 | |
| TOTAL REVENUE | | | | | | | 1,601,486 | | | | 2,044,562 | |
| | | | | | | | | | | | | |
| COST OF SALES | | | 6 | | | | (1,158,052 | ) | | | (1,228,412 | ) |
| | | | | | | | | | | | | |
| GROSS PROFIT | | | | | | | 443,434 | | | | 816,150 | |
| | | | | | | | | | | | | |
| OPERATING EXPENSES | | | | | | | | | | | | |
| Amortization | | | 11 | | | | 8,989 | | | | 44,540 | |
| Depreciation | | | 10,12 | | | | 57,506 | | | | 47,147 | |
| Director fees | | | 20 | | | | 151,663 | | | | 107,446 | |
| Insurance | | | | | | | 498,006 | | | | 1,458,765 | |
| Office and miscellaneous | | | 19 | | | | 2,800,652 | | | | 1,607,837 | |
| Professional fees | | | | | | | 847,187 | | | | 873,640 | |
| Research and development | | | | | | | 793,224 | | | | 314,440 | |
| Share-based payments | | | 17, 20 | | | | 540,563 | | | | 643,325 | |
| Travel | | | | | | | 89,262 | | | | 76,472 | |
| Wages and salaries | | | 20 | | | | 1,821,081 | | | | 1,000,207 | |
| Total operating expenses | | | | | | | (7,608,133 | ) | | | (6,173,819 | ) |
| OTHER INCOME (EXPENSE) | | | | | | | | | | | | |
| Change in fair value of derivative liability | | | 17 | | | | 57,314 | | | | (1,230,860 | ) |
| Finance and other gain (loss) | | | | | | | 35,861 | | | | 14,148 | |
| Foreign exchange gain (loss) | | | | | | | (18,156 | ) | | | (386,940 | ) |
| Gain (loss) on disposal of assets | | | | | | | 21,203 | | | | (10,755 | ) |
| Gain on recovery of notes receivable | | | 7 | | | | - | | | | 771,260 | |
| Government income | | | | | | | 1,275 | | | | 1,275 | |
| Other expense | | | | | | | (424 | ) | | | (4,794 | ) |
| Total other income (expenses) | | | | | | | 97,073 | | | | (846,666 | ) |
| | | | | | | | | | | | | |
| NET LOSS | | | | | | | (7,067,626 | ) | | | (6,204,335 | ) |
| | | | | | | | | | | | | |
| OTHER COMPREHENSIVE INCOME (LOSS) | | | | | | | | | | | | |
| Items that may be reclassified to profit or loss | | | | | | | | | | | | |
| Foreign exchange translation | | | | | | | (86,402 | ) | | | (54,910 | ) |
| Items that will not be reclassified to profit or loss | | | | | | | | | | | | |
| Change in fair value of equity investments at FVOCI | | | 9 | | | | 57,033 | | | | (33,249 | ) |
| COMPREHENSIVE LOSS | | | | | | $ | (7,096,995 | ) | | $ | (6,292,494 | ) |
| | | | | | | | | | | | | |
| Net loss per share | | | | | | | | | | | | |
| Basic & diluted | | | | | | $ | (0.20 | ) | | $ | (0.19 | ) |
| Weighted average number of common shares outstanding - basic & diluted | | | | | | | 34,689,118 | | | | 33,185,860 | |
The accompanying notes are an integral part of these consolidated interim financial statements.
Draganfly Inc.
Condensed Consolidated Interim Statements of Changes in Shareholders’ Equity - Unaudited
Expressed in Canadian Dollars
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | Accumulated Other Comprehensive Income (Loss) | | | | |
| | | Number of Shares | | | Share Capital | | | Reserve – Share-Based Payments | | | Accumulated Deficit | | | Change in Fair Value of Investments at FVTOCI | | | Exchange Differences on Translation of Foreign Operations | | | Total Shareholders’ Equity | |
| Balance at December 31, 2021 | | | 33,168,946 | | | $ | 81,038,365 | | | $ | 6,406,117 | | | $ | (52,322,182 | ) | | $ | (332,640 | ) | | $ | 136,579 | | | $ | 34,926,239 | |
| Shares issued for exercise of stock options | | | 12,500 | | | | 51,875 | | | | (25,000 | ) | | | - | | | | - | | | | - | | | | 26,875 | |
| Shares issued for exercise of warrants | | | 16,538 | | | | 74,227 | | | | - | | | | - | | | | - | | | | - | | | | 74,227 | |
| Share issue costs | | | - | | | | (5,122 | ) | | | - | | | | - | | | | - | | | | - | | | | (5,122 | ) |
| Share-based payments | | | - | | | | - | | | | 643,325 | | | | - | | | | - | | | | - | | | | 643,325 | |
| Net loss | | | - | | | | - | | | | - | | | | (6,204,335 | ) | | | - | | | | - | | | | (6,204,335 | ) |
| Change in fair value of equity investments at FVOCI | | | - | | | | - | | | | - | | | | - | | | | (33,249 | ) | | | - | | | | (33,249 | ) |
| Translation of foreign operations | | | - | | | | - | | | | - | | | | - | | | | - | | | | (54,910 | ) | | | (54,910 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Balance at March 31, 2022 | | | 33,197,984 | | | $ | 81,159,345 | | | $ | 7,024,442 | | | $ | (58,526,517 | ) | | $ | (365,889 | ) | | $ | 81,669 | | | $ | 29,373,050 | |
| Shares issued for exercise of warrants | | | - | | | | 12,943 | | | | - | | | | - | | | | - | | | | - | | | | 12,943 | |
| Shares issued for the exercise of RSUs | | | 1,072,595 | | | | 2,427,801 | | | | (2,427,801 | ) | | | - | | | | - | | | | - | | | | - | |
| Share-based payments | | | - | | | | - | | | | 2,667,699 | | | | - | | | | - | | | | - | | | | 2,667,699 | |
| Net loss | | | - | | | | - | | | | - | | | | (21,450,029 | ) | | | - | | | | - | | | | (21,450,029 | ) |
| Change in fair value of equity investments at FVOCI | | | - | | | | - | | | | - | | | | - | | | | (65,234 | ) | | | - | | | | (65,234 | ) |
| Translation of foreign operations | | | - | | | | - | | | | - | | | | - | | | | - | | | | 502,452 | | | | 502,452 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Balance at December 31, 2022 | | | 34,270,579 | | | $ | 83,600,089 | | | $ | 7,264,340 | | | $ | (79,976,546 | ) | | $ | (431,123 | ) | | $ | 584,121 | | | $ | 11,040,881 | |
| Balance | | | 34,270,579 | | | $ | 83,600,089 | | | $ | 7,264,340 | | | $ | (79,976,546 | ) | | $ | (431,123 | ) | | $ | 584,121 | | | $ | 11,040,881 | |
The accompanying notes are an integral part of these consolidated interim financial statements.
Draganfly Inc.
Condensed Consolidated Interim Statements of Changes in Shareholders’ Equity - Unaudited
Expressed in Canadian Dollars
| | | | | | | | | | | | | | | Accumulated Other Comprehensive Income (Loss) | | | | |
| | | Number of Shares | | | Share Capital | | | Reserve – Share-Based Payments | | | Accumulated Deficit | | | Change in Fair Value of Investments at FVTOCI | | | Exchange Differences on Translation of Foreign Operations | | | Total Shareholders’ Equity | |
| Shares issued for financing – ATM (“At – the – market”) | | | 650,729 | | | | 1,748,946 | | | | - | | | | - | | | | - | | | | - | | | | 1,748,946 | |
| Share issue costs | | | - | | | | (187,697 | ) | | | - | | | | - | | | | - | | | | - | | | | (187,697 | ) |
| Shares issued for financing | | | 8,000,000 | | | | 10,856,166 | | | | - | | | | - | | | | - | | | | - | | | | 10,856,166 | |
| Share issue costs | | | - | | | | (1,206,040 | ) | | | - | | | | - | | | | - | | | | - | | | | (1,206,040 | ) |
| Shares issued for the exercise of RSUs | | | 63,657 | | | | 68,750 | | | | (68,750 | ) | | | - | | | | - | | | | - | | | | - | |
| Share-based payments | | | - | | | | - | | | | 540,563 | | | | - | | | | - | | | | - | | | | 540,563 | |
| Net loss | | | - | | | | - | | | | - | | | | (7,067,626 | ) | | | - | | | | - | | | | (7,067,626 | ) |
| Change in fair value of equity investments at FVOCI | | | - | | | | - | | | | - | | | | - | | | | 57,033 | | | | - | | | | 57,033 | |
| Translation of foreign operations | | | - | | | | - | | | | - | | | | - | | | | - | | | | (86,402 | ) | | | (86,402 | ) |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Balance at March 31, 2023 | | | 42,984,965 | | | $ | 94,880,214 | | | $ | 7,736,153 | | | $ | (87,044,172 | ) | | $ | (374,090 | ) | | $ | 497,719 | | | $ | 15,695,824 | |
| Balance | | | 42,984,965 | | | $ | 94,880,214 | | | $ | 7,736,153 | | | $ | (87,044,172 | ) | | $ | (374,090 | ) | | $ | 497,719 | | | $ | 15,695,824 | |
The accompanying notes are an integral part of these consolidated interim financial statements.
Draganfly Inc.
Condensed Consolidated Interim Statements of Cash Flows - Unaudited
Expressed in Canadian Dollars
| | | | | | | | | |
| | | For the three months ended
March 31, | |
| | | 2023 | | | 2022 | |
| | | | | | | |
| OPERATING ACTIVITIES | | | | | | | | |
| Net loss | | $ | (7,067,626 | ) | | $ | (6,204,335 | ) |
| Adjustments for: | | | | | | | | |
| Amortization | | | 8,989 | | | | 44,540 | |
| Depreciation | | | 57,506 | | | | 47,147 | |
| Impairment of accounts receivable | | | 198,513 | | | | - | |
| Change in fair value of derivative liability | | | (57,314 | ) | | | 1,230,860 | |
| Impairment of inventory | | | 77,047 | | | | - | |
| Gain on recovery of notes receivable | | | - | | | | (771,260 | ) |
| Finance and other costs | | | 1,275 | | | | (140 | ) |
| Gain on disposal of assets | | | (21,203 | ) | | | - | |
| Income from government assistance | | | - | | | | (1,275 | ) |
| Share-based payments | | | 540,563 | | | | 643,325 | |
| Adjustment for profit loss | | | (6,262,250 | ) | | | (5,011,138 | ) |
| Net changes in non-cash working capital items: | | | | | | | | |
| Receivables | | | 404,458 | | | | (544,318 | ) |
| Inventory | | | (558,352 | ) | | | 25,649 | |
| Prepaids | | | 419,350 | | | | 2,142,325 | |
| Trade payables and accrued liabilities | | | 392,643 | | | | (47,704 | ) |
| Customer deposits | | | 40,467 | | | | 37,401 | |
| Deferred income | | | (59,732 | ) | | | (91,385 | ) |
| Cash used in operating activities | | | (5,623,416 | ) | | | (3,489,170 | ) |
| | | | | | | | | |
| INVESTING ACTIVITIES | | | | | | | | |
| Purchase of equipment | | | (74,415 | ) | | | (23,197 | ) |
| Disposal of equipment | | | 45,774 | | | | 10,755 | |
| Repayment of notes receivable | | | 33,369 | | | | - | |
| Cash provided by (used in) investing activities | | | 4,728 | | | | (12,442 | ) |
| | | | | | | | | |
| FINANCING ACTIVITIES | | | | | | | | |
| Proceeds from issuance of common shares for financing | | | 12,605,112 | | | | - | |
| Share issue costs | | | (1,393,737 | ) | | | (5,122 | ) |
| Proceeds from issuance of common shares for warrants exercised | | | - | | | | 74,227 | |
| Proceeds from issuance of common shares for stock options exercised | | | - | | | | 26,875 | |
| Repayment of loans | | | (1,686 | ) | | | (1,686 | ) |
| Repayment of lease liabilities | | | (30,444 | ) | | | (36,583 | ) |
| Cash provided by (used in) financing activities | | | 11,179,245 | | | | 57,711 | |
| | | | | | | | | |
| Effects of exchange rate changes on cash | | | (86,402 | ) | | | (54,910 | ) |
| Change in cash | | | 5,560,557 | | | | (3,443,901 | ) |
| Cash and cash equivalents, beginning of year | | | 7,894,781 | | | | 23,075,713 | |
| Cash and cash equivalents, end of period | | $ | 13,368,936 | | | $ | 19,576,902 | |
| | | | | | | | | |
| SUPPLEMENTARY CASH FLOW DISCLOSURE | | | | | | | | |
| Interest paid | | $ | 11,817 | | | | 11,195 | |
The accompanying notes are an integral part of these consolidated interim financial statements.
Draganfly Inc.
Notes to the Condensed Consolidated Interim Financial Statements
For the Three Months Ended March 31, 2023
Expressed in Canadian Dollars (unaudited)
1. NATURE AND CONTINUANCE OF OPERATIONS
Draganfly Inc. (the “Company”) was incorporated on June 1, 2018 under the Business Corporations Act (British Columbia). The Company creates quality, cutting-edge unmanned and remote data collection and analysis platforms and systems that are designed to revolutionize the way companies do business. The Company’s shares trade on the Canadian Securities Exchange (the “CSE”), on the Nasdaq Capital Market (the “Nasdaq”) under the symbol “DPRO” and on the Frankfurt Stock Exchange under the symbol “3U8”. The Company’s head office is located at 2108 St. George Avenue, Saskatoon, SK, S7M 0K7 and its registered office is located at 2800 – 666 Burrard Street, Vancouver, BC, V6C 2Z7.
These condensed consolidated interim financial statements have been prepared on the assumption that the Company will continue as a going concern, meaning it will continue in operation for the foreseeable future and will be able to realize assets and discharge liabilities in the ordinary course of operations. To date, the Company has not been profitable and has an accumulated deficit of $87,044,172. The Company’s ability to continue as a going concern is dependent upon its ability to obtain additional financing and or achieve profitable operations in the future. These factors indicate the existence of a material uncertainty that may cast significant doubt on the Company’s ability to continue as a going concern. These financial statements do not reflect adjustments that would be necessary if the going concern assumption were not appropriate. These adjustments could be material.
2. BASIS OF PREPARATION
Statement of Compliance
These condensed consolidated interim financial statements have been prepared in accordance with International Accounting Standard (“IAS”) 34, “Interim Financial Reporting”. These condensed consolidated interim financial statements include all necessary disclosures required from interim financial statements but do not include all disclosures required for annual financial statements. These condensed consolidated interim financial statements should be read in conjunction with the Company’s annual financial statements for the year ended December 31, 2022.
These condensed consolidated interim financial statements were authorized for issue by the Board of Directors on May 9, 2023.
Basis of consolidation
Each subsidiary is fully consolidated from the date of acquisition, being the date on which the Company obtains control, and continue to be consolidated until the date when such control ceases.
The consolidated financial statements include the accounts and results of operations of the Company and its wholly owned subsidiaries listed in the following table:
SCHEDULE OF RESULTS OF OPERATIONS
| Name of Subsidiary | | Place of Incorporation | | | Ownership Interest | |
| Draganfly Innovations Inc. | | | Canada | | | | 100% | |
| Draganfly Innovations USA, Inc. | | | US | | | | 100% | |
| Dronelogics Systems Inc. | | | Canada | | | | 100% | |
All intercompany balances and transactions were eliminated on consolidation.
Draganfly Inc.
Notes to the Condensed Consolidated Interim Financial Statements
For the Three Months Ended March 31, 2023
Expressed in Canadian Dollars (unaudited)
3. SIGNIFICANT ACCOUNTING POLICIES, ESTIMATES, AND JUDGEMENTS
These condensed consolidated interim financial statements have been prepared following the same accounting principles and methods of computation as in outlined in the Company’s consolidated financial statements for the year ended December 31, 2022. A description of the accounting standards and interpretations that have been adopted by the Company can be found in the notes of the annual financials statements for the year ended December 31, 2022.
The preparation of the condensed consolidated interim financial statements requires management to make assumptions and estimates that affect the reported amounts of assets and liabilities at the date of the financial statements and reported amounts of income and expenses during the reporting period. These condensed consolidated interim financial statements include estimates, which by their nature, are uncertain. These assumptions and associated estimates are based on historical experience and other factors that are considered to be relevant. As such, actual results may differ from estimates and the effect of such differences may be material. Significant estimates and judgements used in the preparation of these condensed consolidated interim financial statements remained unchanged from those disclosed in the Company’s annual consolidated financial statements for the year ended December 31, 2022.
4. CASH AND CASH EQUIVALENTS
SCHEDULE OF CASH AND CASH EQUIVALENTS
| | | | | | | | | |
| | | March 31,
2023 | | | December 31,
2022 | |
| Cash held in banks | | $ | 12,965,099 | | | $ | 7,500,607 | |
| Guaranteed investment certificates | | | 403,837 | | | | 394,174 | |
| Cash and Cash Equivalents | | $ | 13,368,936 | | | $ | 7,894,781 | |
5. RECEIVABLES
SCHEDULE OF AMOUNTS RECEIVABLE
| | | | | | | | | |
| | | March 31,
2023 | | | December 31,
2022 | |
| Trade accounts receivable | | $ | 1,469,494 | | | $ | 1,343,795 | |
| Sales tax receivable | | | 16,500 | | | | 745,170 | |
| Trade and other receivables | | $ | 1,485,994 | | | $ | 2,088,965 | |
During the three months ended March 31, 2023, the Company recorded a provision for doubtful accounts of $198,513.
6. INVENTORY
SCHEDULE OF INVENTORIES
| | | | | | | | | |
| | | March 31,
2023 | | | December 31,
2022 | |
| Finished goods | | $ | 1,053,300 | | | $ | 542,934 | |
| Parts | | | 483,947 | | | | 513,008 | |
| Inventories | | $ | 1,537,247 | | | $ | 1,055,942 | |
During the three months ended March 31, 2023, $1,012,881 (2022 - $1,161,511) of inventory was recognized in cost of sales including an allowance to value its inventory for obsolete and slow-moving inventory of $77,047 (2022 - $nil).
Cost of sales consist of the following:
SCHEDULE OF COST OF SALES
| | | | | | | | | |
| | | March 31,
2023 | | | March 31,
2022 | |
| Inventory | | $ | 1,012,881 | | | $ | 1,161,511 | |
| Consulting and services | | | 93,654 | | | | 64,833 | |
| Other | | | 51,517 | | | | 2,068 | |
| Cost of sales | | $ | 1,158,052 | | | $ | 1,228,412 | |
7. NOTE RECEIVABLE
DISCLOSURE OF NOTES RECEIVABLE
| | | | Maturity Date | | Rate | | | Principal | | | Interest | | | Accretion | | | (Impairment)/ Recovery | | | Repayments | | | Balance
March 31,
2023 | |
| Note 1(1) | | | 2023-06-30 | | | 0 | % | | $ | 168,699 | | | $ | - | | | $ | - | | | $ | - | | | $ | (33,369 | ) | | $ | 135,330 | |
| (1) | These notes are denominated in US dollars. |
Draganfly Inc.
Notes to the Condensed Consolidated Interim Financial Statements
For the Three Months Ended March 31, 2023
Expressed in Canadian Dollars (unaudited)
7. NOTE RECEIVABLE (CONT’D)
Note 1 was issued on April 4, 2021, is non-interest bearing and is secured by intellectual property. The face value of the note was $150,000 USD and the original maturity date was October 21, 2022. This note is measured at fair value through profit or loss. The parties agreed on an amended maturity date, whereby $34,860 ($25,000 USD) was paid on October 21, 2022, the original maturity date, and the remaining balance was to be paid January 21, 2023. The parties mutually agreed to extend the maturity date to March 31, 2023, with a partial repayment of $33,369 ($25,000 USD) paid on January 30, 2023. Subsequent to the period ending March 31, 2023, the parties mutually agreed to extend the maturity date whereby a partial repayment of $13,533 ($10,000 USD) was paid on April 28, 2023, with the remaining balance to be paid on June 30, 2023.
During the three months ended March 31, 2022, a note receivable that has been subsequently fully paid had an impairment recovery of $771,260 after the parties agreed on a repayment plan.
8. PREPAIDS AND DEPOSITS
SCHEDULE OF PREPAID EXPENSES AND DEPOSITS
| | | | | | | | | |
| | | March 31,
2023 | | | December 31,
2022 | |
| Insurance | | $ | 675,171 | | | $ | 1,148,455 | |
| Prepaid interest | | | 1,619 | | | | 1,889 | |
| Prepaid marketing services | | | 381,107 | | | | 733,417 | |
| Prepaid rent | | | 12,480 | | | | 12,485 | |
| Prepaid subscriptions | | | 17,831 | | | | 29,194 | |
| Deposits | | | 800,166 | | | | 382,284 | |
| Prepaid expenses and deposits | | $ | 1,888,374 | | | $ | 2,307,724 | |
9. INVESTMENTS
SCHEDULE OF INVESTMENTS
| | | | | |
| Balance at December 31, 2022 | | $ | 192,583 | |
| Balance | | | 192,583 | |
| Change in fair value | | | 57,033 | |
| Balance at March 31, 2023 | | $ | 249,616 | |
| Balance | | $ | 249,616 | |
Fair value of investments is comprised of:
SCHEDULE OF FAIR VALUE OF INVESTMENT
| | | | | |
| Public company shares | | $ | 114,286 | |
| Private company shares | | | 135,330 | |
| Balance at March 31, 2023 | | $ | 249,616 | |
| Fair value of investments | | $ | 249,616 | |
On March 10, 2021, the Company purchased 1,428,571 units of a publicly listed company for $500,000. Each unit is comprised of one common share and one warrant. The warrants have an exercise price of $0.50 each and convert to one common share, and expired on March 17, 2023. The fair values of these warrants were estimated using the Black-Scholes option pricing model with the following assumptions:
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR FAIR VALUES WARRANTS
| | | December 31,
2022 | |
| Risk free interest rate | | | 4.07 | % |
| Expected volatility | | | 116.00 | % |
| Expected life | | | 0.21 years | |
| Expected dividend yield | | | 0 | % |
On October 27, 2021, the Company purchased 50,000 common shares of a private company for USD$100,000. The Company considers if observable market data exists on a quarterly basis to value the investment. Since inception, the Company has not had any adjustments to the fair value of the investment based on observable market data.
Draganfly Inc.
Notes to the Condensed Consolidated Interim Financial Statements
For the Three Months Ended March 31, 2023
Expressed in Canadian Dollars (unaudited)
10. EQUIPMENT
SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | Computer Equipment | | | Furniture and Equipment | | | Leasehold Improvements | | | Software | | | Vehicles | | | Total | |
| Cost | | | | | | | | | | | | | | | | | | | | | | | | |
| Balance at December 31, 2021 | | $ | 54,110 | | | $ | 342,472 | | | $ | 4,352 | | | $ | 29,967 | | | $ | 36,033 | | | $ | 466,934 | |
| Additions | | | 60,240 | | | | 528,080 | | | | - | | | | - | | | | - | | | | 588,320 | |
| Disposals | | | (18,688 | ) | | | (36,099 | ) | | | (4,352 | ) | | | (29,967 | ) | | | - | | | | (89,106 | ) |
| Balance at December 31, 2022 | | | 95,662 | | | $ | 834,453 | | | | - | | | | - | | | | 36,033 | | | | 966,148 | |
| Property, plant and equipment, cost, beginning balance | | $ | 95,662 | | | $ | 834,453 | | | $ | - | | | $ | - | | | $ | 36,033 | | | $ | 966,148 | |
| Additions | | | 7,510 | | | | 66,905 | | | | - | | | | - | | | | - | | | | 74,415 | |
| Disposals | | | - | | | | (75,437 | ) | | | - | | | | - | | | | - | | | | (75,437 | ) |
| Balance at March 31, 2023 | | $ | 103,172 | | | $ | 825,921 | | | $ | - | | | $ | - | | | $ | 36,033 | | | $ | 965,126 | |
| Property, plant and equipment, cost, ending balance | | $ | 103,172 | | | $ | 825,921 | | | $ | - | | | $ | - | | | $ | 36,033 | | | $ | 965,126 | |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| Accumulated depreciation | | | | | | | | | | | | | | | | | | | | | | | | |
| Balance at December 31, 2021 | | $ | 25,291 | | | $ | 102,277 | | | $ | 4,352 | | | $ | 24,737 | | | $ | 13,234 | | | $ | 169,891 | |
| Charge for the year | | | 32,627 | | | | 433,855 | | | | - | | | | - | | | | 3,435 | | | | 469,917 | |
| Disposals | | | (15,920 | ) | | | (33,342 | ) | | | (4,352 | ) | | | (24,737 | ) | | | - | | | | (78,351 | ) |
| Balance at December 31, 2022 | | | 41,998 | | | | 502,790 | | | | - | | | | - | | | | 16,669 | | | | 561,457 | |
| Accumulated depreciation Property, plant and equipment, beginning balance | | $ | 41,998 | | | $ | 502,790 | | | $ | - | | | $ | - | | | $ | 16,669 | | | $ | 561,457 | |
| Charge for the period | | | 4,325 | | | | 20,888 | | | | - | | | | - | | | | 1,453 | | | | 26,666 | |
| Disposals | | | - | | | | (50,866 | ) | | | - | | | | - | | | | - | | | | (50,866 | ) |
| Balance at March 31, 2023 | | $ | 46,323 | | | $ | 472,812 | | | $ | - | | | $ | - | | | $ | 18,122 | | | $ | 537,257 | |
| Accumulated depreciation Property, plant and equipment, ending balance | | $ | 46,323 | | | $ | 472,812 | | | $ | - | | | $ | - | | | $ | 18,122 | | | $ | 537,257 | |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| Net book value: | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2022 | | $ | 53,664 | | | $ | 331,663 | | | $ | - | | | $ | - | | | $ | 19,364 | | | $ | 404,691 | |
| March 31, 2023 | | $ | 56,849 | | | $ | 353,109 | | | $ | - | | | $ | - | | | $ | 17,911 | | | $ | 427,869 | |
| Property, plant and equipment, net | | $ | 56,849 | | | $ | 353,109 | | | $ | - | | | $ | - | | | $ | 17,911 | | | $ | 427,869 | |
11. INTANGIBLE ASSETS AND GOODWILL
SCHEDULE OF INTELLECTUAL PROPERTY
| | | - | | | | - | | | | - | | | | (1) | | | | | | | | |
| | | Patents | | | Customer Relationships | | | Brand | | | Software (1) | | | Goodwill | | | Total | |
| Cost | | | | | | | | | | | | | | | | | | | | | | | | |
| Balance at December 31, 2021 | | $ | 41,931 | | | $ | 197,000 | | | $ | 23,000 | | | $ | 552,000 | | | $ | 5,940,409 | | | $ | 6,754,340 | |
| Cost, beginning balance | | $ | 41,931 | | | $ | 197,000 | | | $ | 23,000 | | | $ | 552,000 | | | $ | 5,940,409 | | | $ | 6,754,340 | |
| Additions | | | - | | | | - | | | | - | | | | 4,684 | | | | - | | | | 4,684 | |
| Foreign exchange translation | | | - | | | | - | | | | 1,571 | | | | 29,576 | | | | 257,782 | | | | 288,929 | |
| Impairment | | | - | | | | - | | | | (24,571 | ) | | | (462,577 | ) | | | (6,198,191 | ) | | | (6,685,339 | ) |
| Balance at December 31, 2022 and March 31, 2023 | | $ | 41,931 | | | $ | 197,000 | | | $ | - | | | $ | 123,683 | | | $ | - | | | $ | 362,614 | |
| Cost, ending balance | | $ | 41,931 | | | $ | 197,000 | | | $ | - | | | $ | 123,683 | | | $ | - | | | $ | 362,614 | |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| Accumulated amortization | | | | | | | | | | | | | | | | | | | | | | | | |
| Balance at December 31, 2021 | | $ | 41,931 | | | $ | 60,414 | | | $ | 3,450 | | | $ | 114,235 | | | $ | - | | | $ | 220,030 | |
| Charge for the year | | | - | | | | 27,317 | | | | 4,719 | | | | 147,446 | | | | - | | | | 179,482 | |
| Foreign exchange translation | | | - | | | | - | | | | 431 | | | | 13,295 | | | | - | | | | 13,726 | |
| Impairment | | | - | | | | - | | | | (8,600 | ) | | | (221,825 | ) | | | - | | | | (230,425 | ) |
| Balance at December 31, 2022 | | | 41,931 | | | | 87,731 | | | | - | | | | 53,151 | | | | - | | | | 182,813 | |
| Accumulated amortization, beginning balance | | $ | 41,931 | | | $ | 87,731 | | | $ | - | | | $ | 53,151 | | | $ | - | | | $ | 182,813 | |
| Charge for the period | | | - | | | | 5,463 | | | | - | | | | 3,526 | | | | - | | | | 8,989 | |
| Balance at March 31, 2023 | | $ | 41,931 | | | $ | 93,194 | | | $ | - | | | $ | 56,677 | | | $ | - | | | $ | 191,802 | |
| Accumulated amortization, ending balance | | $ | 41,931 | | | $ | 93,194 | | | $ | - | | | $ | 56,677 | | | $ | - | | | $ | 191,802 | |
| | | | | | | | | | | | | | | | | | | | | | | | | |
Net book value: | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2022 | | $ | - | | | $ | 109,269 | | | $ | - | | | $ | 70,532 | | | $ | - | | | $ | 179,801 | |
| March 31, 2023 | | $ | - | | | $ | 103,806 | | | $ | - | | | $ | 67,006 | | | $ | - | | | $ | 170,812 | |
| Net book value | | $ | - | | | $ | 103,806 | | | $ | - | | | $ | 67,006 | | | $ | - | | | $ | 170,812 | |
| (1) | Software acquired via acquisition of Vital and Dronelogics. |
Draganfly Inc.
Notes to the Condensed Consolidated Interim Financial Statements
For the Three Months Ended March 31, 2023
Expressed in Canadian Dollars (unaudited)
12. RIGHT OF USE ASSETS
SCHEDULE OF RIGHT OF USE ASSETS
| | | Total | |
| Cost | | | | |
| Balance at December 31, 2022 and March 31, 2023 | | $ | 683,117 | |
| | | | | |
| Accumulated depreciation | | | | |
| Balance at December 31, 2021 | | $ | 215,011 | |
| Charge for the year | | | 123,360 | |
| Balance at December 31, 2022 | | $ | 338,371 | |
| Charge for the period | | | 30,840 | |
| Balance at March 31, 2023 | | $ | 369,211 | |
| | | | | |
| Net book value: | | | | |
| December 31, 2022 | | $ | 344,746 | |
| March 31, 2023 | | $ | 313,906 | |
13. LEASE LIABILITES
The Company leases certain assets under lease agreements. The lease liabilities consist of leases of facilities and vehicles with terms ranging from one to five years. The leases are calculated using incremental borrowing rates ranging from 7.5% to 10.5%
SCHEDULE OF OPERATING LEASE LIABILITIES
| | | | | | Total | |
| Balance at December 31, 2021 | | | | | | $ | 489,123 | |
| Interest expense | | | | | | | 39,795 | |
| Lease payments | | | | | | | (150,275 | ) |
| Balance at December 31, 2022 | | | | | | | 378,643 | |
| Interest expense | | | | | | | 8,220 | |
| Lease payments | | | | | | | (38,664 | ) |
| Balance at March 31, 2023 | | | | | | $ | 348,199 | |
| | | | | | | | | |
| Which consists of: | | | | | | | | |
| | | | March 31,
2023 | | | | December 31,
2022 | |
| Current lease liability | | $ | 108,898 | | | $ | 133,962 | |
| Non-current lease liability | | | 239,301 | | | | 244,681 | |
| Ending balance | | $ | 348,199 | | | $ | 378,643 | |
SCHEDULE OF OPERATING MATURITY ANALYSIS
| Maturity analysis | | Total | |
| Less than one year | | $ | 134,610 | |
| One to three years | | | 209,308 | |
| Four to five years | | | 57,686 | |
| Total undiscounted lease liabilities | | | 401,604 | |
| Amount representing interest | | | (53,405 | ) |
| Lease liability | | $ | 348,199 | |
14. TRADE PAYABLES AND ACCRUED LIABILITIES
SCHEDULE OF TRADE PAYABLES AND ACCRUED LIABILITIES
| | | | | | | | | |
| | | March 31,
2023 | | | December 31,
2022 | |
| Trade accounts payable | | $ | 1,460,545 | | | $ | 751,422 | |
| Accrued liabilities | | | 1,714,464 | | | | 2,031,545 | |
| Government grant payable | | | 33,709 | | | | 33,709 | |
| Trade payables and accrued liabilities | | $ | 3,208,718 | | | $ | 2,816,676 | |
Draganfly Inc.
Notes to the Condensed Consolidated Interim Financial Statements
For the Three Months Ended March 31, 2023
Expressed in Canadian Dollars (unaudited)
15. DEFERRED INCOME
At times, the Company may take payment in advance for services to be rendered. These amounts are held and recognized as services are rendered.
SCHEDULE OF DEFERRED INCOME
| | | | | | | | | |
| | | March 31,
2023 | | | December 31,
2022 | |
| Deferred income from customers | | $ | - | | | $ | 58,457 | |
| Deferred income from government | | | 3,958 | | | | 5,233 | |
| Deferred Income | | $ | 3,958 | | | $ | 63,690 | |
16. LOANS PAYABLE
SCHEDULE OF LOANS PAYABLE
| | | | | | | | | |
| | | March 31,
2023 | | | December 31,
2022 | |
| Opening balance | | $ | 86,571 | | | $ | 93,317 | |
| Fair value adjustment | | | - | | | | (4,891 | ) |
| Repayment of loans payable | | | (1,686 | ) | | | (6,746 | ) |
| Accretion expense | | | 1,275 | | | | 4,891 | |
| Ending balance | | $ | 86,160 | | | $ | 86,571 | |
Which consists of:
| | | March 31, 2023 | | | December 31, 2022 | |
| Current loans payable | | $ | 82,787 | | | $ | 81,512 | |
| Beginning balance | | $ | 82,787 | | | $ | 81,512 | |
| Non-current loans payable | | | 3,373 | | | | 5,059 | |
| Ending balance | | $ | 86,160 | | | $ | 86,571 | |
SCHEDULE OF LOANS
| | | | | | | | | | | | | | | | |
| | | Start Date | | Maturity Date | | Rate | | Carrying Value March 31, 2023 | | | Carrying Value December 31, 2022 | |
| CEBA | | 2020-05-19 | | 2023-12-31 | | | 0% | | $ | 38,021 | | | $ | 37,383 | |
| CEBA | | 2021-04-23 | | 2023-12-31 | | | 0% | | | 38,021 | | | | 37,383 | |
| Vehicle loan | | 2019-08-30 | | 2024-09-11 | | | 6.99% | | | 10,118 | | | | 11,805 | |
| Total | | | | | | | | | $ | 86,160 | | | $ | 86,571 | |
The CEBA loans are unsecured, and the vehicle loan is secured by the vehicle.
Draganfly Inc.
Notes to the Condensed Consolidated Interim Financial Statements
For the Three Months Ended March 31, 2023
Expressed in Canadian Dollars (unaudited)
17. SHARE CAPITAL
Authorized share capital
Unlimited number of common shares without par value.
Issued share capital
During the three months ended March 31, 2023,
| | ● | The Company issued 63,657 common shares for the vesting of restricted share units. |
| | ● | The Company issued 8,000,000 common shares in a financing for $10,856,166 with share issuance costs of $1,206,040 for net proceeds of $9,650,126; and |
| | ● | The Company issued 650,729 common shares in an ATM financing for 1,748,946 with share issuance costs of $187,697 for net proceeds of $1,561,249. |
During the year ended December 31, 2022,
| | ● | The Company issued 16,538 common shares for the exercise of warrants for $92,292 with share issuance costs of $5,122 for net proceeds of $87,170. |
| | ● | The Company issued 12,500 common shares for the exercise of stock options for $26,875; and |
| | ● | The Company issued 1,072,595 common shares for the vesting of restricted share units. |
Stock Options
The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the CSE requirements, grant to directors, officers, employees, and technical consultants to the Company, non-transferable stock options to purchase common shares. The total number of common shares reserved and available for grant and issuance pursuant to this plan shall not exceed 20% (in the aggregate) of the issued and outstanding common shares from time to time. The number of options awarded and underlying vesting conditions are determined by the Board of Directors in its discretion.
As at March 31, 2023, the Company had the following options outstanding and exercisable:
SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE
| Grant Date | | Expiry Date | | Exercise Price | | | Remaining Contractual Life (years) | | | Number of Options Outstanding | | | Number of Options Exercisable | |
| October 30, 2019 | | October 30, 2029 | | $ | 2.50 | | | | 6.59 | | | | 286,665 | | | | 286,665 | |
| November 19, 2019 | | November 19, 2029 | | $ | 2.50 | | | | 6.64 | | | | 50,000 | | | | 50,000 | |
| April 30, 2020 | | April 30, 2030 | | $ | 2.50 | | | | 7.09 | | | | 85,000 | | | | 85,000 | |
| April 30, 2020 | | April 30, 2030 | | $ | 3.85 | | | | 7.09 | | | | 110,000 | | | | 110,000 | |
| July 3, 2020 | | July 3, 2025 | | $ | 3.20 | | | | 2.26 | | | | 100,000 | | | | 100,000 | |
| November 24, 2020 | | November 24, 2030 | | $ | 2.50 | | | | 7.66 | | | | 32,000 | | | | 32,000 | |
| February 2, 2021 | | February 2, 2031 | | $ | 13.20 | | | | 7.85 | | | | 30,000 | | | | 20,000 | |
| March 8, 2021 | | March 8, 2026 | | $ | 13.90 | | | | 2.94 | | | | 10,000 | | | | 10,000 | |
| April 27, 2021 | | April 27, 2031 | | $ | 10.15 | | | | 8.08 | | | | 147,666 | | | | 50,326 | |
| September 9, 2021 | | September 9, 2026 | | $ | 4.84 | | | | 3.45 | | | | 25,826 | | | | 8,608 | |
| | | | | | | | | | | | | | 877,157 | | | | 752,599 | |
SCHEDULE OF STOCK OPTIONS OUTSTANDING AND EXERCISABLE
| | | Number of Options | | | Weighted Average Exercise Price | |
| Outstanding, December 31, 2021 | | | 1,035,991 | | | $ | 4.60 | |
| Exercised | | | (12,500 | ) | | | 2.15 | |
| Forfeited | | | (146,334 | ) | | | 4.77 | |
| Outstanding, December 31, 2022 and March 31, 2023 | | | 877,157 | | | $ | 4.60 | |
No options were granted by the Company during the three months ended March 31, 2023
Draganfly Inc.
Notes to the Condensed Consolidated Interim Financial Statements
For the Three Months Ended March 31, 2023
Expressed in Canadian Dollars (unaudited)
17. SHARE CAPITAL (CONT’D)
During the three months ended March 31, 2023, the Company recorded $103,012 (2022 - $297,566) in stock-based compensation in relation to the vesting of stock options. The fair values of stock options granted were estimated using the Black-Scholes option pricing model.
Restricted Share Units
During the three months ended March 31, 2023, the Company recorded share-based payment expense of $437,551 (2022 - $345,759) for RSUs, based on the fair values of RSUs granted which were calculated using the closing price of the Company’s stock on the day prior to grant.
The Company has adopted an incentive share compensation plan, which provides that the Board of Directors of the Company may from time to time, in its discretion, and in accordance with the Exchange requirements, grant to directors, officers, employees and technical consultants to the Company, restricted stock units (RSUs). The number of RSUs awarded and underlying vesting conditions are determined by the Board of Directors in its discretion. RSUs will have a 3-year vesting period following the award date. The total number of common shares reserved and available for grant and issuance pursuant to this plan, and the total number of Restricted Share Units that may be awarded pursuant to this plan, shall not exceed 20% (in the aggregate) of the issued and outstanding common shares from time to time.
As at March 31, 2023, the Company had the following RSUs outstanding:
SUMMARY OF CHANGES IN RESTRICTED STOCK UNITS
| | | Number of RSUs | |
| Outstanding, December 31, 2021 | | | 514,832 | |
| Vested | | | (1,072,595 | ) |
| Issued | | | 1,820,972 | |
| Forfeited | | | (64,334 | ) |
| Outstanding, December 31, 2022 | | | 1,198,875 | |
| Vested | | | (63,657 | ) |
| Forfeited | | | (24,334 | ) |
| Outstanding, March 31, 2023 | | | 1,110,884 | |
Warrants
During the years ended December 31, 2021 and 2020, the Company issued warrants (“USD Warrants”) with a USD exercise price. Being in a foreign currency that is not the Company’s functional currency and these warrants were not issued in exchange for services, these USD Warrants are required to be recorded as a financial liability and not as equity. As a financial liability, these USD Warrants are revalued on a quarterly basis to fair market value with the change in fair value being recorded profit or loss. The initial fair value of these USD Warrants was parsed out from equity and recorded as a financial liability.
To reach a fair value of the USD Warrants, a Black Scholes calculation is used, calculated in USD as the Company also trades on the Nasdaq. The Black Scholes value per USD Warrant is then multiplied by the number of outstanding warrants and then multiplied by the foreign exchange rate at the end of the period from the Bank of Canada.
Warrant Derivative Liability
SCHEDULE OF WARRANT DERIVATIVE LIABILITY
| Balance at December 31, 2021 | | $ | 4,865,772 | |
| Change in fair value of warrants outstanding | | | (4,865,772 | ) |
| Balance at December 31, 2022 and March 31, 2023 | | $ | - | |
| Derivative liability balance at | | March 31,
2023 | | | December 31,
2022 | |
| Contingent liability | | $ | - | | | $ | 57,314 | |
| Ending balance | | $ | - | | | $ | 57,314 | |
Draganfly Inc.
Notes to the Condensed Consolidated Interim Financial Statements
For the Three Months Ended March 31, 2023
Expressed in Canadian Dollars (unaudited)
17. SHARE CAPITAL (CONT’D)
The contingent liability is related to an acquisition on March 22, 2021, whereby 1,200,000 warrants were issued and 900,000 were held in escrow and classified as a contingent liability that was to be released upon completion of the milestones. The warrants expired on March 25, 2023.
Details of these warrants and their fair values are as follows:
SCHEDULE OF WARRANTS AND FAIR VALUE OUTSTANDING
| Issue Date | | Exercise Price | | | Number of Warrants Outstanding at March 31, 2023 | | | Fair Value at March 31, 2023 | | | Number of Warrants Outstanding at December 31, 2022(5) | | | Fair Value at December 31, 2022 | |
| February 5, 2021 (1) | | | US$ 3.55 | | | | - | | | | - | | | | 1,319,675 | | | | - | |
| March 5, 2021 (2) | | | US$ 3.55 | | | | - | | | | - | | | | 5,142,324 | | | | - | |
| July 29, 2021 (3) | | | US$ 5.00 | | | | 250,000 | | | | - | | | | 250,000 | | | | - | |
| September 14, 2021 (4) | | | US$ 5.00 | | | | 4,798 | | | | - | | | | 4,798 | | | | - | |
| | | | | | | | 254,798 | | | $ | - | | | | 6,716,797 | | | $ | - | |
| | 1) | The warrants expired on February 5, 2023. |
| | 2) | The warrants expired on March 5, 2023. |
| | 3) | The warrants expire July 29, 2024. |
| | 4) | The warrants expire September 14, 2024. |
| | 5) | The number of warrants outstanding does not include the 1,200,000 warrants that are classified as a contingent liability. |
The fair values of these warrants were estimated using the Black-Scholes option pricing model with the following weighted average assumptions:
SCHEDULE OF WEIGHTED AVERAGE ASSUMPTION FOR WARRANTS
| | | March 31,
2023 | | | December 31,
2022 | |
| Risk free interest rate | | | - | | | | 4.07 | % |
| Expected volatility | | | - | | | | 91.66%-93.48 | % |
| Expected life | | | - | | | | 0.10-0.18 years | |
| Expected dividend yield | | | - | | | | 0 | % |
Volatility is calculated using the historical volatility method.
SUMMARY OF CHANGES IN WARRANTS
| | | Number of Warrants | | | Weighted Average Exercise Price | |
| Outstanding, December 31, 2021 | | | 8,414,819 | | | $ | 4.99 | |
| Exercised | | | (16,538 | ) | | | 4.51 | |
| Expired | | | (481,484 | ) | | | 4.61 | |
| Outstanding, December 31, 2022 | | | 7,916,797 | | | $ | 5.08 | |
| Expired | | | (7,661,999 | ) | | | 5.89 | |
| Outstanding March 31, 2023 | | | 254,798 | | | $ | 6.23 | |
As at March 31, 2023, the Company had the following warrants outstanding:
SCHEDULE OF WARRANTS OUTSTANDING
| Date issued | | Expiry date | | Exercise price | | | Number of warrants outstanding | |
| July 29, 2021 | | July 29, 2024 | | | US$ 5.00 | | | | 250,000 | |
| September 14, 2021 | | September 14, 2024 | | | US$ 5.00 | | | | 4,798 | |
| | | | | | | | | | 254,798 | |
The weighted average remaining contractual life of warrants outstanding as of March 31, 2023, was 1.33 years (December 31, 2022 – 0.47 years).
Draganfly Inc.
Notes to the Condensed Consolidated Interim Financial Statements
For the Three Months Ended March 31, 2023
Expressed in Canadian Dollars (unaudited)
18. SEGMENTED INFORMATION
The Company organizes its three segments based on product lines as well as a Corporate segment. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. The Company aggregates the information for the segments by analyzing the revenue steam and allocating direct costs to that respective segment. The Corporate segment is aggregated by relying on the entity that includes corporate costs (Draganfly Inc.)
SCHEDULE OF SEGMENTED INFORMATION
| March 31, 2023 | | Drones | | | Vital | | | Corporate | | | Total | |
| Sales of goods | | $ | 1,380,816 | | | $ | - | | | $ | - | | | $ | 1,380,816 | |
| Provision of services | | | 220,670 | | | | - | | | | - | | | | 220,670 | |
| Total revenue | | | 1,601,486 | | | | - | | | | - | | | | 1,601,486 | |
| Segment loss | | | 4,545,828 | | | | 73,817 | | | | 2,397,614 | | | | 7,017,259 | |
| Finance and other costs | | | (34,304 | ) | | | - | | | | (1,557 | ) | | | (35,861 | ) |
| Depreciation | | | 55,113 | | | | - | | | | 2,393 | | | | 57,506 | |
| Amortization | | | 8,989 | | | | - | | | | - | | | | 8,989 | |
| Change in fair value of derivative liability | | | - | | | | - | | | | (57,314 | ) | | | (57,314 | ) |
| Loss on write-off of notes receivable | | | - | | | | - | | | | - | | | | - | |
| Loss on write down of inventory | | | 77,047 | | | | - | | | | - | | | | 77,047 | |
| Net loss for the year | | $ | 4,652,673 | | | $ | 73,817 | | | $ | 2,341,136 | | | $ | 7,067,626 | |
| March 31, 2022 | | Drones | | | Vital | | | Corporate | | | Total | |
| Sales of goods | | $ | 1,518,019 | | | $ | 119,697 | | | $ | - | | | $ | 1,637,716 | |
| Provision of services | | | 406,846 | | | | - | | | | - | | | | 406,846 | |
| Total revenue | | | 2,044,562 | | | | 119,697 | | | | - | | | | 2,044,562 | |
| Segment loss | | | 1,261,521 | | | | 102,661 | | | | 4,303,014 | | | | 5,667,196 | |
| Finance and other costs | | | (14,148 | ) | | | - | | | | - | | | | (14,148 | ) |
| Depreciation | | | 47,147 | | | | - | | | | - | | | | 47,147 | |
| Amortization | | | 10,955 | | | | 33,585 | | | | - | | | | 44,540 | |
| Change in fair value of derivative liability | | | - | | | | - | | | | 1,230,860 | | | | 1,230,860 | |
| Loss on write-off of notes receivable | | | - | | | | - | | | | (771,260 | ) | | | (771,260 | ) |
| Net loss for the year | | $ | 1,305,475 | | | $ | 136,246 | | | $ | 4,762,614 | | | $ | 6,204,335 | |
SCHEDULE OF GEOGRAPHIC REVENUE
| | | 2023 | | | 2022 | |
| Geographic revenue segmentation is as follows: | | For the three months ended
March 31, | |
| | | 2023 | | | 2022 | |
| Canada | | $ | 1,592,094 | | | $ | 1,467,830 | |
| United States | | | 9,392 | | | | 576,732 | |
| Revenue | | $ | 1,601,486 | | | $ | 2,044,562 | |
Geographic revenue is measured by aggregating sales based on the country and the entity where the sale was made.
19. OFFICE AND MISCELLANEOUS
SCHEDULE OF OFFICE AND MISCELLANEOUS EXPENSES
| | | 2023 | | | 2022 | |
| | | For the three months ended
March 31, | |
| | | 2023 | | | 2022 | |
| Advertising, Marketing, and Investor Relations | | $ | 2,306,452 | | | $ | 1,159,773 | |
| Compliance fees | | | 27,307 | | | | 47,380 | |
| Impairment of accounts receivable | | | 198,513 | | | | - | |
| Contract Work | | | 47,081 | | | | 214,848 | |
| Other | | | 221,299 | | | | 185,836 | |
| Office and Miscellaneous Expenses | | $ | 2,800,652 | | | $ | 1,607,837 | |
Draganfly Inc.
Notes to the Condensed Consolidated Interim Financial Statements
For the Three Months Ended March 31, 2023
Expressed in Canadian Dollars (unaudited)
20. RELATED PARTY TRANSACTIONS
Trade receivables/payables and accrued receivables/payables:
As at March 31, 2023, the Company had $nil (2022 - $155,108) receivable from related parties outstanding that were included in accounts receivable and $22,350 (2022 - $nil) payable from related parties that was included in accounts payable. The balances outstanding are unsecured, non-interest bearing and due on demand.
Key management compensation
Key management personnel include those persons having authority and responsibility for planning, directing and controlling the activities of the Company as a whole. Compensation awarded to key management for the three months ended March 31, 2023 and 2022 included:
SCHEDULE OF KEY COMPENSATION AWARDS
| For the three months ended March 31, | | 2023 | | | 2022 | |
| Director fees | | $ | 151,663 | | | $ | 107,446 | |
| Salaries | | | 102,115 | | | | 127,565 | |
| Share-based payments | | | 263,242 | | | | 322,083 | |
| Total | | $ | 517,020 | | | $ | 557,094 | |
Other related party transactions
SCHEDULE OF KEY MANAGEMENT TRANSACTIONS
| For the three months ended March 31, | | 2023 | | | 2022 | |
| Management fees paid to a company controlled by CEO and director | | $ | 100,000 | | | $ | 100,000 | |
| Management fees paid to a company that the CEO holds an economic interest in | | | 103,629 | | | | 125,732 | |
| Management fees paid to a company controlled by the former President and director | | | 58,398 | | | | 62,500 | |
| Management fees paid to a company | | | 58,398 | | | | 62,500 | |
| Total | | $ | 262,027 | | | $ | 288,232 | |
21. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT
The Company is exposed in varying degrees to a variety of financial instrument related risks. The Board of Directors approves and monitors the risk management processes, inclusive of documented investment policies, counterparty limits, and controlling and reporting structures. The type of risk exposure and the way in which such exposure is managed is provided as follows:
Credit risk
Credit risk is the risk that one party to a financial instrument will fail to discharge an obligation and cause the other party to incur a financial loss. The Company’s primary exposure to credit risk is on its cash held in bank accounts and trade receivables.
An expected credit loss (ECL) analysis is performed at each reporting date. The provision amounts are based on direct management consultation with the customer. The calculations reflect the probability-weighted outcome with reasonable and supportable information that is available at the reporting date while also considering past events as well as current and future economic conditions. Accounts receivables are written off when there is no reasonable expectation of recovery which indicators include amongst others, business failure, failure to make contractual payments, and the failure of a debtor to engage in a repayment plan.
Trade receivables include balances of $836,346 that are past due with no corresponding allowance recorded. Subsequent to March 31, 2023, the Company received $312,000 related to these receivables.
The majority of cash is deposited in bank accounts held with major bank in Canada and the United States. As most of the Company’s cash is held by one bank there is a concentration of credit risk. This risk is managed by using major banks that are high credit quality financial institutions as determined by rating agencies. The Company does have past due outstanding receivables however the expected loss rate for undue balance is estimated to be nominal.
Fair value
A number of the Company’s accounting policies and disclosures require the measurement of fair values for financial assets and liabilities. The Company has established a control framework with respect to the measurement of fair values. Fair values are categorized into different levels of a fair value hierarchy based on the inputs used in the valuation techniques as follows:
Draganfly Inc.
Notes to the Condensed Consolidated Interim Financial Statements
For the Three Months Ended March 31, 2023
Expressed in Canadian Dollars (unaudited)
21. FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (CONT’D)
Level 1: quoted (unadjusted) prices in active markets for identical assets or liabilities.
Level 2: other techniques for which all inputs which have a significant effect on the recorded fair value are observable, either directly or indirectly.
Level 3: techniques which use inputs which have a significant effect on the recorded fair value that are not based on observable market data.
Equity securities in investee companies and warrants are measured at fair value. The financial assets and liabilities measured at fair value by hierarchy are shown in the table below. The amounts shown are based on the amounts recognized in the statements of financial position. These financial assets are measured at fair value through profit and loss.
SCHEDULE OF FINANCIAL ASSETS MEASURED FAIR VALUE THROUGH PROFIT AND LOSS
| March 31, 2023 | | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
| Equity securities in investee companies | | $ | 114,286 | | | $ | 135,330 | | | $ | - | | | $ | 249,616 | |
| Notes receivable | | | - | | | | - | | | | 135,330 | | | | 135,330 | |
| Total | | $ | 114,286 | | | $ | 135,330 | | | $ | 135,330 | | | $ | 384,946 | |
| December 31, 2022 | | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
| Equity securities in investee companies | | $ | 57,143 | | | $ | 135,440 | | | $ | - | | | $ | 192,583 | |
| Notes receivable | | | - | | | | - | | | | 169,300 | | | | 169,300 | |
| Derivative liability | | | - | | | | - | | | | 57,314 | | | | 57,314 | |
| Total | | $ | 57,143 | | | $ | 135,440 | | | $ | 226,614 | | | $ | 419,197 | |
22. SUBSEQUENT EVENT
Subsequent to March 31, 2023, a note receivable with an original maturity date of October 21, 2022 was amended to June 30th, 2023. The parties agreed on an amended maturity date, whereby $13,533 ($10,000 USD) was paid on April 28th, 2023. The note remains non-interest bearing and secured by intellectual property.
